Home Spurious increase in serum chromogranin A: the role of heterophilic antibodies
Article
Licensed
Unlicensed Requires Authentication

Spurious increase in serum chromogranin A: the role of heterophilic antibodies

  • Luca Giovanella and Luca Ceriani
Published/Copyright: July 29, 2010

Abstract

Background: The aim of the study was to examine the prevalence of heterophilic antibody (HAb) interference on serum chromogranin A (CgA) measurements.

Methods: Serum CgA was measured in 672 serum samples before and following incubation in heterophilic antibody blocking tubes (HBTs). Results showing more than 3 and 5 SD percentage difference from the original result were considered to be affected by possible or definite HAb interference, respectively. All possible interferences were confirmed or excluded by non-linear or linear dilution tests.

Results: Following HBT treatment, CgA concentrations fell >3 SD percent compared with the original result in seven specimens, six of which also showed non-linear dilution (0.9%). A clinically relevant increase in serum CgA occurred in five patients (0.7%). No samples showed a significant increase of >3 SD percent following HBT treatment.

Conclusions: Interference from HAb occurred in up to 0.9% of sera tested for serum CgA. If an increased CgA result does not fit the clinical picture, pretreatment of serum in HBT tubes may prevent unwarranted investigations or therapies.

Clin Chem Lab Med 2010;48:1497–9.


Corresponding author: PD Dr. med. Luca Giovanella, Nuclear Medicine and Thyroid Centre, Oncology Institute of Southern Switzerland, Via Ospedale 12, 6500 Bellinzona, Switzerland Phone: +41 91-811 86 72, Fax: +41 91-811 82 50,

Received: 2010-3-24
Accepted: 2010-5-3
Published Online: 2010-07-29
Published in Print: 2010-10-01

©2010 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorial
  2. Darwinian evolution or regression? The fate of laboratory professionals
  3. Review
  4. Automated reticulocyte counting: state of the art and clinical applications in the evaluation of erythropoiesis
  5. Minireview
  6. Laboratory diagnostics in acute poisoning: critical overview
  7. Opinion Papers
  8. On the origins of physicians: Darwinian or Lamarckian evolution?
  9. Observed, unknown distributions of clinical chemical quantities should be considered to be log-normal: a proposal
  10. Guidelines and Recommendations
  11. Development and description of GETT: a Genetic testing Evidence Tracking Tool
  12. Genetics and Molecular Diagnostics
  13. DNA sequencing errors in molecular diagnostics of filamin myopathy
  14. High resolution melting for the identification of mutations in the iron responsive element of the ferritin light chain gene
  15. General Clinical Chemistry and Laboratory Medicine
  16. Detection of serum free light chains: the problem with antigen excess
  17. Hepcidin concentrations and iron homeostasis in preeclampsia
  18. Automated assay for non-transferrin-bound iron in serum samples
  19. A simple liquid chromatography-tandem mass spectrometry method for urinary free cortisol analysis: suitable for routine purpose
  20. Evaluation of a multiplex assay for adipokine concentrations in obese children
  21. The use of serial patient blood gas, electrolyte and glucose results to derive biologic variation: a new tool to assess the acceptability of intensive care unit testing
  22. Point-of-care determination of neonatal bilirubin with the blood gas analyzer RapidLab 1265
  23. The effect of pre-analytical variables on light transmittance aggregometry in citrated platelet-rich plasma from healthy subjects
  24. Cancer Diagnostics
  25. Clinical significance of serum macrophage-colony stimulating factor (M-CSF) in esophageal cancer patients and its comparison with classical tumor markers
  26. VKORC1 haplotypes influence the performance characteristics of PIVKAII for screening of hepatocellular carcinoma
  27. Serum soluble tumour necrosis factor receptor type I concentrations independently predict prognosis in patients with breast cancer
  28. Variations in systemic biomarkers of oxidative/nitrosative stress and DNA damage before and during the consequent two cycles of chemotherapy in breast cancer patients
  29. Spurious increase in serum chromogranin A: the role of heterophilic antibodies
  30. Infectious Diseases
  31. Identification and evaluation of a new nucleic acid amplification test target for specific detection of Mycobacterium tuberculosis
  32. Application of an oligonucleotide microarray-based nano-amplification technique for the detection of fungal pathogens
  33. Liquid chromatography-tandem mass spectrometry method for simultaneous quantification of four triazole antifungal agents in human plasma
  34. Evaluation of two sirolimus assays using the ARCHITECT-i1000® CMIA or RxL® ACMIA methods in comparison with the IMx® MEIA method
  35. Widespread use of point-of-care testing is irreconcilable with the present-day quest for safety
  36. Congress Abstracts
  37. 3rd Annual Congress of the Austrian Society for Laboratory Medicine and Clinical Chemistry Salzburg, Austria, 27-30 October 2010
Downloaded on 11.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2010.293/html
Scroll to top button